Co-Diagnostics and CoSara to Launch IVD Products to India Market
January 02, 2020 06:30 ET
|
Co-Diagnostics
Salt Lake City, Jan. 01, 2020 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company”), a molecular diagnostics company with a unique, patented platform for the development of...
Co-Diagnostics, Inc. Continues to Execute on International Expansion
October 29, 2019 06:30 ET
|
Co-Diagnostics
Salt Lake City, Oct. 29, 2019 (GLOBE NEWSWIRE) -- Salt Lake City, Utah – October 29, 2019 – Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company”), a molecular diagnostics company with a unique,...
Co-Diagnostics, Inc. Adds to Menu of Molecular Vector Control Products
October 10, 2019 06:30 ET
|
Co-Diagnostics
Salt Lake City, Oct. 10, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic...
Co-Diagnostics to Present Technology Applications at 4th ACTC Liquid Biopsy Conference in Corfu, Greece
October 03, 2019 06:30 ET
|
Co-Diagnostics
Salt Lake City, UT, Oct. 03, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular...
Co-Diagnostics, Inc. to Launch Vector Control Products into Midwest US at OPMA Conference
September 19, 2019 06:30 ET
|
Co-Diagnostics
Salt Lake City, UT, Sept. 19, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular...
Co-Diagnostics, Inc. and LGC, Biosearch Technologies Expand License Agreement for CoPrimer™ Technology
September 04, 2019 06:30 ET
|
Co-Diagnostics
Salt Lake City, Utah, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX) (“Co-Diagnostics,” or the “Company”), a molecular diagnostics company with a unique, patented platform...
Co-Diagnostics, Inc. to Present at 21st Annual Rodman & Renshaw Global Investment Conference Sept 8-10, 2019
August 28, 2019 06:30 ET
|
Co-Diagnostics
Salt Lake City, Utah, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular...
Co-Diagnostics, Inc. to Host 2nd Semiannual Distributor Conference on Sept 10-12
August 21, 2019 06:30 ET
|
Co-Diagnostics
Salt Lake City, Utah, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular...
Co-Diagnostics, Inc Reports Quarter on Quarter Sales Growth for Q2 2019
August 14, 2019 17:05 ET
|
Co-Diagnostics
Salt Lake City, UT, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular...
Co-Diagnostics, Inc. to Present Products and Services at the 2019 AACC Expo August 4-8
August 01, 2019 06:30 ET
|
Co-Diagnostics
Salt Lake City, Utah, Aug. 01, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular...